The optimal anti-tumor effects of anti-CTLA-4 antibody therapy required specific Bacteroides species including Bacteroides thetaiotaomicron and Bacteroides fragilis in mice and humans with melanoma (29). The gene discussed is CTLA4; the disease is neoplasm.